Feed for /statutes/statutes/450 PDF
450.095   Duty to dispense contraceptives.
450.10   Disciplinary proceedings; immunity; orders.
450.11   Prescription drugs and prescription devices.
450.115   Drug disposal programs and authorizations.
450.12   Labeling of prescription drugs and prescription drug products.
450.125   Drugs for animal use.
450.13   Using drug product equivalent in dispensing prescriptions.
450.14   Poisons.
450.145   Reporting potential causes of public health emergency.
450.15   Placing prescription drugs prohibited.
450.155   Exhibition, display or advertisement of certain vending machines by use of certain material prohibited.
450.16   Sale of contraceptives prohibited in certain areas.
450.17   Violations.
450.18   Penalties.
450.19   Prescription drug monitoring program.
Ch. 450 Cross-reference Cross-reference: See definitions in s. 440.01.
Ch. 450 Cross-reference Cross-reference: See also Phar, Wis. adm. code.
450.01 450.01 Definitions. In this chapter:
450.01(1) (1) "Administer" means the direct application of a vaccine or a prescribed drug or device, whether by injection, ingestion or any other means, to the body of a patient or research subject by any of the following:
450.01(1)(a) (a) A practitioner or his or her authorized agent.
450.01(1)(b) (b) A patient or research subject at the direction of a practitioner.
450.01(1)(c) (c) A pharmacist.
450.01(1)(d) (d) In the case of an opioid antagonist, any person.
450.01(1m) (1m) "Advanced practice nurse prescriber" means an advanced practice nurse who is certified under s. 441.16 (2).
450.01(1p) (1p) "Affiliated group" has the meaning given in section 1504 of the Internal Revenue Code.
450.01(1t) (1t) "Authenticate" means to affirmatively verify, before wholesale distribution of a prescription drug occurs, that each transaction listed on a pedigree has occurred.
450.01(1x) (1x) "Authorized distributor of record" means a wholesale distributor with whom a manufacturer has established an ongoing relationship to distribute the manufacturer's prescription drug. For purposes of this subsection, an ongoing relationship exists between a wholesale distributor and a manufacturer if all of the following apply:
450.01(1x)(a) (a) The wholesale distributor, including any affiliated group of the wholesale distributor, has in effect a written agreement with the manufacturer evidencing the ongoing relationship.
450.01(1x)(b) (b) The wholesale distributor, including any affiliated group of the wholesale distributor, is included in the manufacturer's current list of authorized distributors of record.
450.01(2) (2) "Board" means the pharmacy examining board.
450.01(2m) (2m) "Colicensed" means, with respect to a partner or product, that 2 or more parties have the right to engage in marketing or manufacturing of a product consistent with the federal food and drug administration's implementation of the federal prescription drug marketing act.
450.01(3) (3) "Compound" means to mix, combine or put together various ingredients or drugs for the purpose of dispensing.
450.01(4) (4) "Controlled substance" has the meaning designated in s. 961.01 (4).
450.01(5) (5) "Deliver" or "delivery" means the actual, constructive or attempted transfer of a drug or device from one person to another.
450.01(6) (6) "Device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component, part or accessory, which does not achieve any of its principal intended purposes through chemical action within or on the body of a person or other animal, is not dependent upon being metabolized for the achievement of any of its principal intended purposes and is:
450.01(6)(a) (a) Recognized by the U.S. pharmacopoeia and national formulary or official homeopathic pharmacopoeia of the United States, or any supplement to either of them;
450.01(6)(b) (b) Intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or other conditions in persons or other animals; or
450.01(6)(c) (c) Intended to affect the structure or any function of the body of persons or other animals.
450.01(7) (7) "Dispense" means to deliver a prescribed drug or device to an ultimate user or research subject by or pursuant to the prescription order of a practitioner, including the compounding, packaging or labeling necessary to prepare the prescribed drug or device for delivery.
450.01(8) (8) "Distribute" means to deliver, other than by administering or dispensing.
450.01(9) (9) "Distributor" means a person licensed by the board under s. 450.07 (2).
450.01 Note NOTE: Section 450.07 (2) was repealed by 2007 Wis. Act 20.
450.01(9m) (9m) "Drop shipment" means a sale of a prescription drug to a wholesale distributor by the manufacturer of the drug, by the manufacturer's colicensed product partner, by the manufacturer's 3rd party logistics provider, or by the manufacturer's exclusive distributor, to which all of the following apply:
450.01(9m)(a) (a) The wholesale distributor or chain pharmacy warehouse takes title to, but not physical possession of, the drug.
450.01(9m)(b) (b) The wholesale distributor invoices a pharmacy, a chain pharmacy warehouse, or a person authorized to dispense or administer the drug to a patient.
450.01(9m)(c) (c) The pharmacy, chain pharmacy warehouse, or person authorized to dispense or administer the drug receives delivery of the drug directly from the manufacturer, the manufacturer's 3rd party logistics provider, or the manufacturer's exclusive distributor.
450.01(10) (10) "Drug" means:
450.01(10)(a) (a) Any substance recognized as a drug in the official U.S. pharmacopoeia and national formulary or official homeopathic pharmacopoeia of the United States or any supplement to either of them;
450.01(10)(b) (b) Any substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or other conditions in persons or other animals;
450.01(10)(c) (c) Any substance other than a device or food intended to affect the structure or any function of the body of persons or other animals; or
450.01(10)(d) (d) Any substance intended for use as a component of any article specified in pars. (a) to (c) but does not include gases or devices or articles intended for use or consumption in or for mechanical, industrial, manufacturing or scientific applications or purposes.
450.01(11) (11) "Drug product" means a specific drug or drugs in a specific dosage form and strength from a known source of manufacture.
450.01(11m) (11m) "Facility" means a location where a wholesale distributor stores, handles, repackages, or offers for sale prescription drugs.
450.01(11r) (11r) "Intracompany sales" means any transaction or transfer between any division, subsidiary, parent, or affiliated or related company under common ownership and control of a corporate entity or any transaction or transfer between colicensees of a colicensed product.
450.01(12) (12) "Manufacturer" means a person licensed or approved by the federal food and drug administration to engage in the manufacture of drugs or devices, consistent with the definition of "manufacturer" under the federal food and drug administration's regulations and interpreted guidances implementing the federal prescription drug marketing act.
450.01(12m) (12m) "Manufacturer's exclusive distributor" means a person that contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of the manufacturer and who takes title to the manufacturer's prescription drug but who does not have general responsibility to direct the sale or disposition of the drug.
450.01(13) (13) "Manufacturing" means making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
450.01(13m) (13m) "Nonprescription drug product" means any nonnarcotic drug product which may be sold without a prescription order and which is prepackaged for use by consumers and labeled in accordance with the requirements of state and federal law.
450.01(13r) (13r)
450.01(13r)(a)(a) "Normal distribution channel" means a chain of custody for a prescription drug that runs, directly or by drop shipment, from the manufacturer of a drug, from the manufacturer to the manufacturer's colicensed partner, from the manufacturer to the manufacturer's 3rd-party logistics provider, or from the manufacturer to the manufacturer's exclusive distributor, and continues as described in any of the following:
450.01(13r)(a)1. 1. To a pharmacy or to a person authorized to dispense or administer a drug to a patient.
450.01(13r)(a)2. 2. To an authorized distributor of record, and then to a pharmacy or to a person authorized to dispense or administer a drug to a patient.
450.01(13r)(a)3. 3. To an authorized distributor of record, then to one other authorized distributor of record, then to an office-based practitioner.
450.01(13r)(a)4. 4. To a pharmacy warehouse to the pharmacy warehouse's intracompany pharmacy, then to a patient or to a person authorized to dispense or administer a drug to a patient.
450.01(13r)(a)5. 5. To an authorized distributor of record, then to a pharmacy warehouse, then to the pharmacy warehouse's intracompany pharmacy, then to a patient or to a person authorized to dispense or administer a drug to a patient.
450.01(13r)(b) (b) For purposes of this subsection, a distribution of a prescription drug to a warehouse or to another entity that redistributes the drug by intracompany sale to a pharmacy or to another person authorized to dispense or administer the drug constitutes a distribution to the pharmacy or to the person authorized to dispense or administer the drug.
450.01(13v) (13v) "Opioid antagonist" means a drug, such as naloxone, that satisfies all of the following:
450.01(13v)(a) (a) The drug binds to the opioid receptors and competes with or displaces opioid agonists at the opioid receptor site but does not activate the receptors, effectively blocking the receptor and preventing or reversing the effect of an opioid agonist.
450.01(13v)(b) (b) The drug is not a controlled substance.
450.01(14) (14) "Patient" means the person or other animal for whom drug products or devices are prescribed or to whom drug products or devices are dispensed or administered.
450.01(14m) (14m) "Pedigree" means a document or electronic file containing information that records each distribution of a prescription drug.
450.01(15) (15) "Pharmacist" means a person licensed by the board under s. 450.03 or 450.05.
450.01(15m) (15m) "Pharmacy warehouse" means a physical location for prescription drugs that acts as a central warehouse and performs intracompany sales.
450.01(15r) (15r) "Physician assistant" has the meaning given in s. 448.01 (6).
450.01(16) (16) "Practice of pharmacy" means any of the following:
450.01(16)(a) (a) Interpreting prescription orders.
450.01(16)(b) (b) Compounding, packaging, labeling, dispensing and the coincident distribution of drugs and devices.
450.01(16)(c) (c) Participating in drug utilization reviews.
450.01(16)(d) (d) Proper and safe storage of drugs and devices and maintaining proper records of the drugs and devices.
450.01(16)(e) (e) Providing information on drugs or devices which may include, but is not limited to, advice relating to therapeutic values, potential hazards and uses.
450.01(16)(f) (f) Drug product substitution under s. 450.13.
450.01(16)(g) (g) Supervision of pharmacist supportive personnel.
450.01(16)(h) (h) Making therapeutic alternate drug selections, if made in accordance with written guidelines or procedures previously established by a pharmacy and therapeutics committee of a hospital and approved by the hospital's medical staff and use of the therapeutic alternate drug selection has been approved for a patient during the period of the patient's stay within the hospital by any of the following:
450.01(16)(h)1. 1. The patient's physician.
450.01(16)(h)2. 2. The patient's advanced practice nurse prescriber, if the advanced practice nurse prescriber has entered into a written agreement to collaborate with a physician.
450.01(16)(h)3. 3. The patient's physician assistant.
450.01(16)(hm) (hm) Making therapeutic alternate drug selections in accordance with written guidelines or procedures previously established by a quality assessment and assurance committee of a nursing facility under s. 49.498 (2) (a) 3. or by a committee established for a nursing home under s. 50.045 (2), if the use of the therapeutic alternate drug selection has been approved for a patient during the period of the patient's stay within the nursing facility or nursing home by any of the following:
450.01(16)(hm)1. 1. The patient's personal attending physician.
Loading...
Loading...
2011-12 Wisconsin Statutes updated though 2013 Wis. Act 380 and all Supreme Court Orders entered before June 30, 2014. Published and certified under s. 35.18. Changes effective after July 1, 2014 are designated by NOTES. (Published 7-1-14)